InBios International Inc:企業の製品パイプライン分析

◆英語タイトル:InBios International Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME15191PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal antibodies. Its services comprise research and development and contract manufacturing. The company’s contract manufacturing services comprise reagent preparation, packaging and kit assembly, assay development, computerized label printing, liquid filling, product and process validation, and others. It markets its products across the US. InBios International is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InBios International Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
InBios International Inc Company Overview
InBios International Inc Company Snapshot
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc – Pipeline Analysis Overview
InBios International Inc – Key Facts
InBios International Inc – Major Products and Services
InBios International Inc Pipeline Products by Development Stage
InBios International Inc Pipeline Products Overview
DENV Detect IgA Capture ELISA
DENV Detect IgA Capture ELISA Product Overview
Leprosy Detect ELISA Kit
Leprosy Detect ELISA Kit Product Overview
Malaria Pf/Pv Detect Rapid Test
Malaria Pf/Pv Detect Rapid Test Product Overview
Multiplex Test
Multiplex Test Product Overview
Point-Of-Care Diagnostic Test – Anthrax
Point-Of-Care Diagnostic Test – Anthrax Product Overview
SCoV-2 Ag Detect Rapid Test
SCoV-2 Ag Detect Rapid Test Product Overview
SCoV-2 Detect IgM/IgG Rapid Test
SCoV-2 Detect IgM/IgG Rapid Test Product Overview
Smart Detect SARS-CoV-2 rRT-PCR Kit
Smart Detect SARS-CoV-2 rRT-PCR Kit Product Overview
Strongyloides Detect IgG ELISA
Strongyloides Detect IgG ELISA Product Overview
InBios International Inc – Key Competitors
InBios International Inc – Key Employees
InBios International Inc – Locations And Subsidiaries
Head Office
Recent Developments
InBios International Inc, Recent Developments
Sep 03, 2019: Zika diagnostic test granted market authorization by FDA
May 23, 2019: FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies
Sep 11, 2018: InBios receives FDA Clearance for its DENV Detect NS1 ELISA Test for early detection of Dengue Fever
Sep 26, 2017: HHS advances point-of-care diagnostic test for anthrax
Dec 22, 2016: FDA Warns Health Care Providers Against Relying Solely on Zika Virus Serological IgM Assay Results
Aug 01, 2016: HHS awards $5.1 million to InBios to advance Zika Diagnostic
Apr 08, 2011: Inbios Receives FDA Approval To Market Test To Help Diagnose Dengue Fever
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc Pipeline Products by Equipment Type
InBios International Inc Pipeline Products by Indication
InBios International Inc, Key Facts
InBios International Inc, Major Products and Services
InBios International Inc Number of Pipeline Products by Development Stage
InBios International Inc Pipeline Products Summary by Development Stage
DENV Detect IgA Capture ELISA - Product Status
DENV Detect IgA Capture ELISA - Product Description
Leprosy Detect ELISA Kit - Product Status
Leprosy Detect ELISA Kit - Product Description
Malaria Pf/Pv Detect Rapid Test - Product Status
Malaria Pf/Pv Detect Rapid Test - Product Description
Multiplex Test - Product Status
Multiplex Test - Product Description
Point-Of-Care Diagnostic Test - Anthrax - Product Status
Point-Of-Care Diagnostic Test - Anthrax - Product Description
SCoV-2 Ag Detect Rapid Test - Product Status
SCoV-2 Ag Detect Rapid Test - Product Description
SCoV-2 Detect IgM/IgG Rapid Test - Product Status
SCoV-2 Detect IgM/IgG Rapid Test - Product Description
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Status
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Description
Strongyloides Detect IgG ELISA - Product Status
Strongyloides Detect IgG ELISA - Product Description
InBios International Inc, Key Employees
Glossary

★海外企業調査レポート[InBios International Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Donaldson Company, Inc.:戦略・SWOT・企業財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kyowa Hakko Kirin Co., Ltd.:企業の戦略・SWOT・財務情報
    Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Samsung Electronics Co Ltd (005930):医療機器:M&Aディール及び事業提携情報
    Summary Samsung Electronics Co Ltd (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, …
  • Sicon Ltd:企業の戦略・SWOT・財務情報
    Sicon Ltd - Strategy, SWOT and Corporate Finance Report Summary Sicon Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EWA Government Systems, Inc.:企業の戦略・SWOT・財務情報
    EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Heron Therapeutics Inc (HRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-base …
  • Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • Kinpo Electronics Inc (2312):企業の財務・戦略的SWOT分析
    Kinpo Electronics Inc (2312) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lamar Advertising Company:企業の戦略・SWOT・財務分析
    Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report Summary Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Versartis Inc (VSAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Versartis Inc (Versartis) is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GHD) that is designed to reduc …
  • Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報
    Summary HLS Therapeutics Inc (HLS Therapeutics) is a pharmaceutical company that offers central nervous system and cardiovascular therapeutic products. The company's product includes clozaril, absorica, vascepa and trinomial. Its clozapine is a pharmaceutical product used in the treatment of schizop …
  • Wegmans Food Markets, Inc.:企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Century Plyboards (India) Ltd:企業の戦略・SWOT・財務情報
    Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Revolution Medicines Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug development company that discovers and develops new medicines and therapies for cancer patients. The company’s programs include SHP2 Program, 4EBP1 Program and mTORC1 Program. It develops REVBLOCKS platform, an integrated suite of mod …
  • Synergy Pharmaceuticals Inc (SGYP):製薬・医療:M&Aディール及び事業提携情報
    Summary Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases. The company pioneered its R&D efforts to develop its proprietary uroguanylin-based GI platform. It is also developing analogs of uro …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆